rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
52
|
pubmed:dateCreated |
1996-2-8
|
pubmed:abstractText |
Long terminal repeat (LTR) of human immunodeficiency virus (HIV) type 1 is activated by thyroid hormone (T3) receptor alpha (T3R alpha) in the absence of ligand. Addition of T3 reverses this effect. This activity is mediated by a high affinity T3 response element (T3RE) within the HIV-1 LTR, termed the HIV-T3RE (bases -74 to -50), which coincides with the Sp1 element as demonstrated by mobility shift, DNaseI footprinting, and methylation interference analyses. HIV-T3RE mediates ligand-independent activation of transcription by T3R alpha when linked to a heterologous promoter. In addition, the viral transactivator Tat synergizes with T3R alpha to activate the HIV-1 LTR in the absence of T3, which is relieved in its presence. These findings have implications for the possible control of HIV-1 LTR activity by T3.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Gene Products, tat,
http://linkedlifedata.com/resource/pubmed/chemical/Ligands,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Retinoic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Thyroid Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Retinoid X Receptors,
http://linkedlifedata.com/resource/pubmed/chemical/Sp1 Transcription Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Trans-Activators,
http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factors,
http://linkedlifedata.com/resource/pubmed/chemical/Triiodothyronine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0021-9258
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
29
|
pubmed:volume |
270
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
31059-64
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8537364-Base Sequence,
pubmed-meshheading:8537364-Binding Sites,
pubmed-meshheading:8537364-Cells, Cultured,
pubmed-meshheading:8537364-DNA-Binding Proteins,
pubmed-meshheading:8537364-Gene Products, tat,
pubmed-meshheading:8537364-HIV Long Terminal Repeat,
pubmed-meshheading:8537364-Ligands,
pubmed-meshheading:8537364-Molecular Sequence Data,
pubmed-meshheading:8537364-Receptors, Retinoic Acid,
pubmed-meshheading:8537364-Receptors, Thyroid Hormone,
pubmed-meshheading:8537364-Retinoid X Receptors,
pubmed-meshheading:8537364-Sp1 Transcription Factor,
pubmed-meshheading:8537364-Trans-Activators,
pubmed-meshheading:8537364-Transcription Factors,
pubmed-meshheading:8537364-Triiodothyronine
|
pubmed:year |
1995
|
pubmed:articleTitle |
A unique thyroid hormone response element in the human immunodeficiency virus type 1 long terminal repeat that overlaps the Sp1 binding sites.
|
pubmed:affiliation |
Department of Pharmacology, School of Medicine, University of California, San Diego, La Jolla 92093-0636, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|